IP Library Granted Patent US 7,081,112
Granted Patent B2
US 7,081,112 · App. 10/215,357 · Granted Jul 25, 2006

Cryogenically enhanced intravascular interventions

Assignee: Cryovascular Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,081,112
App. No.
10/215,357
Granted
Jul 25, 2006
Kind
B2
Abstract

The invention provides techniques and devices for treating atherosclerotic disease using controlled cryogenic cooling, often in combination with angioplusty. The efficacy of endolusninal cryogenic cooling is enhanced by cooling of target tissues using an insulated cryogenic balloon, the lnsulation ideally comprising a fluid which undergoes a phase change at a predetermined temperature. A combination cryogenic/angioplasty catheter avoids exchange procedures between dilation of a stenotic region within a vessel wall and the application of cryogenic cooling. The combination angioplasty/cryogenic cooling catheter may cool the diseased blood vessel before, during, and/or after dilation. Controlled cooling of the vessel wall may change its mechanical properties, weakening the vessel and allowing it to be expanded at a much lower pressure than with conventional uncooled angioplasty. Similar reductions in restenosis may be provided for other primary treatments of the blood vessel, including directional arthrectomy, rotational arthrectomy, laser angioplasty, stenting, and the like.

Claims (11)

1. A method for treating a blood vessel region, the method comprising:

dilating the blood vessel region;

cooling an inner surface of the blood vessel region to a temperature in a range from about 5° C. to about 15° C., while dilating the blood vessel region with a balloon, by introducing a cooling fluid into the balloon as a liquid and changing a phase of the cooling fluid to a gas within the balloon so that the cooling fluid inflates the balloon and simultaneoualy cools the blood vessel region, wherein the blood vessel region is cooled such that observed subsequent excessive cell growth induced stenosis of the blood vessel is inhibited.

2. The method of claim 1 , wherein the cooling fluid comprises N 2 O.

3. The method of claim 1 , wherein the cooling step is performed so as to cool the inner surface of the blood vessel to about 5° C.

4. The method of claim 1 , wherein the cooling step is performed so as to cool the inner surface of the blood vessel to about 10° C.

5. The method of claim 1 , wherein the cooling step effects an observed relative reduction of stenosis of at least about 16 % as compared to a stenosis of an equivalently treated uncooled blood vessel region.

6. The method of claim 1 , wherein the cooling step is performed so as to induce apoptosis.

7. A method for treating a blood vessel region, the method comprising:

positioning a balloon of a balloon catheter along the blood vessel region;

cooling and dilating an inner surface of the blood vessel region by introducing a cooling fluid into the balloon as a liquid and changing a phase of the cooling fluid to a gas within the balloon so that the cooling fluid inflates the balloon and simultaneously cools the blood vessel region, wherein the cooling fluid cools the inner surface of the blood vessel region to a temperature in arange from about 5° C. to about 15° C.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2010
From: CRYOVASCULAR SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 024626/0933 →
TERMINATION OF PATENT SECURITY INTEREST Recorded Apr 25, 2005
From: PRESIDIO MANAGEMENT GROUP, INC., AS COLLATERAL AGENT
To: CRYOVASCULAR SYSTEMS, INC.
Reel/Frame 015931/0804 →
SECURITY INTEREST Recorded May 23, 2003
From: CRYOVASCULAR SYSTEMS, INC.
To: PEQOUT PRIVATE EQUITY FUND III, L.P.; USVP V. INTERNATIONAL L.P.; USVP V ENTREPRENEUR PARTNERS, L.P.; U.S. VENTURE PARTNERS V, L.P.; 2180 ASSOCIATES FUND V, L.P.; DENOVO (Q) VENTURES I, L.P.; DEVOVO VENTURES, I, L.P.; GUIDANT INVESTMENT CORPORATION; SARATOGA VENTURES III, L.P.; SAPIENT CAPITAL, L.P.
Reel/Frame 014097/0141 →
Continuity (4)
Continuation 0951119100 · Feb 23, 2000
Provisional Application 6012163700 · Feb 24, 1999
Provisional Application 6016910900 · Dec 6, 1999
Related Publication 20030109912A1 · Jun 12, 2003